NewBridge Pharmaceuticals

NewBridge Pharmaceuticals is a leading regional specialty pharmaceutical company dedicated to bridging access gaps in the Middle East and Africa (MENA) region. Located in Dubai Science Park, North Tower, 17th Floor, Dubai, Dubai 500618, AE, NewBridge Pharmaceuticals partners with top-tier pharma and biotech companies to commercialize USFDA/EMA-approved innovative pharmaceuticals, biologics, and healthcare solutions. The company's strategic focus areas include Oncology, Immunology, Neuroscience, Gastrointestinal, and Nutrition, addressing critical unmet medical needs.

With a strong portfolio of products, NewBridge Pharmaceuticals has established a substantial presence in the region, providing patients with access to essential innovations. Backed by experienced leadership and talented teams, NewBridge Pharmaceuticals offers flexible partnership opportunities and adheres to the highest standards of compliance in commercial, regulatory, and medical affairs. The company's commitment to quality performance makes it a preferred partner for pharmaceutical companies seeking to expand their reach in local markets.

Supported by strong institutional and corporate investors, NewBridge Pharmaceuticals leverages an extensive life science network and diverse investment expertise to achieve its vision of building successful alliances. NewBridge Pharmaceuticals is uniquely positioned to offer a one-stop solution for partners seeking multi-country access in the Middle East and Africa. We invite the management team at NewBridge Pharmaceuticals to create a customized and exclusive company showcase and product listing on our platform, enhancing your market presence and connecting you with new opportunities.